Physician profile
Stephen P Perry
NPI 1043292774
$3,991.34
in general payments reported to CMS, 2019-2025
26 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,312 · 2020: $149 · 2021: $102 · 2022: $137 · 2023: $576 · 2024: $418 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $2,248.31 | 2019-2023 | |
| Astellas Pharma US INC | $368.69 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $165.90 | 2019-2025 | Slynd |
| Biogen, INC. | $141.33 | 2024-2025 | Zurzuvae |
| Intuitive Surgical, INC. | $130.53 | 2022-2024 | |
| Hologic Sales and Service, LLC | $86.44 | 2022-2024 | Acessa Provu System, Coolseal Generator |
| Daiichi Sankyo INC. | $86.14 | 2019-2021 | |
| Pfizer INC. | $85.05 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $81.45 | 2023-2024 | |
| Abbvie INC. | $79.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $71.25 | 2019-2021 | |
| Organon LLC | $63.86 | 2023-2025 | Nexplanon |
| Medtronic, INC. | $58.26 | 2023 | V-Loc 180 |
| Coopersurgical, INC. | $52.69 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $35.46 | 2025 | Myfembree |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $34.18 | 2023 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $30.07 | 2021 | |
| Baxter Healthcare | $28.20 | 2025 | Perclot |
| Therapeuticsmd, INC. | $25.15 | 2019 | |
| Medicem INC. | $21.20 | 2023 | |
| Agile Therapeutics, INC. | $19.01 | 2021 | |
| Lsi Solutions INC | $18.63 | 2024 | Fornisee |
| Bayer Healthcare Pharmaceuticals INC. | $16.67 | 2020 | |
| Dysis Medical, INC. | $16.33 | 2020 | |
| Lupin INC. | $14.43 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.95 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.